Home
Live Updates
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024 : comparemela.com
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
IRVINE, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients
Related Keywords
San Antonio ,
Texas ,
United States ,
American ,
Calmette Guerin ,
Laurence Watts ,
Markd Tyson ,
Cretostimogene Grenadenorepvec ,
Henryb Gonz ,
Intravesical Cretostimogene Grenadenorepvec ,
Globe Newswire Cg Oncology Inc ,
Convention Center ,
Nasdaq ,
American Urological Association ,
Annual Meeting ,
Single Arm Study ,
High Risk ,
Unresponsive Non Muscle Invasive Bladder Cancer ,
Practice Changing Clinical Trials ,
Urologic Oncologist ,
Mayo Clinic ,
Non Muscle Invasive Bladder Cancer ,
Bacillus Calmette Guerin ,
Region ,
comparemela.com © 2020. All Rights Reserved.